These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28537050)

  • 1. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
    Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
    Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis.
    Piekarska K; Zacharczuk K; Wołkowicz T; Mokrzyś M; Wolaniuk N; Nowakowska M; Szempliński S; Dobruch J; Gierczyński R
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):81. PubMed ID: 34876123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.
    Tsu JH; Ma WK; Chan WK; Lam BH; To KC; To WK; Ng TK; Liu PL; Cheung FK; Yiu MK
    Urology; 2015 Jan; 85(1):15-21. PubMed ID: 25444632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.
    Singh P; Kumar A; Yadav S; Prakash L; Nayak B; Kumar R; Kapil A; Dogra PN
    Investig Clin Urol; 2017 Sep; 58(5):365-370. PubMed ID: 28868509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy.
    Qi C; Malczynski M; Schaeffer AJ; Barajas G; Nadler RB; Scheetz MH; Zembower TR
    J Urol; 2013 Dec; 190(6):2026-32. PubMed ID: 23727416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
    Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
    Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Fluoroquinolone Resistant Aerobic Organisms and Efficacy of Rectal Cleaning in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy.
    Kongubol P; Santanirand P; Sirisreetreerux P; Viseshsindh W; Sangkum P
    J Med Assoc Thai; 2016 Jun; 99(6):691-6. PubMed ID: 29901317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
    Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
    Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.